台股 » 個股 » 國邑* » 籌碼相關 » 券商分點績效

國邑*

(6875)
  • 股價
    45.90
  • 漲跌
    ▼2.70
  • 漲幅
    -5.56%
  • 成交量
    550
  • 產業
    上櫃 生技醫療類股▼1.04%
  • 10人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
國邑* (6875)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2026/01/20     後一日»

券商獲利排行 - 2026/01/20

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  5.79%67.7067.7-2402448.7048.745.9
  5.86%57.1057.1-2002048.8048.845.9
  5.88%51.6051.6-1801848.8048.845.9
  6.32%30.9030.9-100104904945.9
  5.85%28.5028.5-1001048.8048.845.9
  6.32%21.7021.7-7074904945.9
  5.52%21.4021.4-80848.6048.645.9
  3.84%15213.1-4484948.749.245.9
  5.69%13.8013.8-50548.7048.745.9
  5.57%13.5013.5-50548.6048.645.9
  5.56%8.108.1-30348.6048.645.9
  5.56%8.108.1-30348.6048.645.9
  5.46%7.907.9-30348.6048.645.9
  7.09%707-20249.4049.445.9
  6.13%303-10148.9048.945.9
  6.04%2.902.9-10148.9048.945.9
  2.98%2.90.12.8-11248.748.648.745.9
  5.75%2.802.8-10148.7048.745.9
  5.65%2.702.7-10148.7048.745.9
  5.56%2.702.7-10148.6048.645.9
  5.56%2.702.7-10148.6048.645.9
  5.56%2.702.7-10148.6048.645.9
  5.46%2.602.6-10148.6048.645.9
  5.46%2.602.6-10148.6048.645.9
  2.63%1.31.3001149.448.75045.9
   00000048.848.8045.9
   00000048.9048.945.9
   0000004949045.9
   00000048.848.8045.9
   00000048.848.8045.9
   00000048.848.948.845.9
   00000048.848.8045.9
   00000048.948.9045.9
   00000048.848.8045.9
   00000048.848.8045.9
   00000048.948.9045.9
   00000048.848.8045.9
  -5.17%-2.50-2.511048.448.4045.9
  -5.36%-2.60-2.611048.548.5045.9
  -5.36%-2.60-2.611048.548.5045.9
  -5.35%-2.60-2.601048.648.548.845.9
  -5.46%-2.60-2.611048.648.6045.9
  -5.46%-2.60-2.611048.648.6045.9
  -5.46%-2.60-2.611048.648.6045.9
  -5.56%-2.70-2.711048.648.6045.9
  -5.56%-2.70-2.711048.648.6045.9
  -5.56%-2.70-2.711048.648.6045.9
  -5.65%-2.70-2.711048.748.7045.9
  -5.65%-2.70-2.711048.748.7045.9
  -5.65%-2.70-2.711048.748.7045.9

券商虧損排行 - 2026/01/20

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -6.47%-31.70-31.7910049.149.148.845.9
  -5.91%-28.80-28.81010048.848.8045.9
  -5.56%-24.30-24.399048.648.6045.9
  -6.33%-18.60-18.66604949045.9
  -3.20%-15.61.6-17.2610448.948.849.245.9
  -6.17%-15.10-15.155048.948.9045.9
  -5.75%-140-1455048.748.7045.9
  -5.69%-13.80-13.855048.748.7045.9
  -5.56%-13.50-13.555048.648.6045.9
  -5.77%-11.20-11.244048.748.7045.9
  -5.58%-10.80-10.844048.648.6045.9
  -1.05%-10.8-7.4-3.41212049.149.348.945.9
  -5.78%-8.40-8.433048.748.7045.9
  -6.42%-6.30-6.322049.149.1045.9
  -5.94%-5.80-5.822048.848.8045.9
  -5.89%-5.80-5.822048.848.8045.9
  -5.75%-5.60-5.622048.748.7045.9
  -5.75%-5.60-5.622048.748.7045.9
  -5.70%-5.50-5.522048.748.7045.9
  -5.60%-5.40-5.422048.648.6045.9
  -5.56%-5.40-5.422048.648.6045.9
  -5.56%-5.40-5.422048.648.6045.9
  -5.56%-5.40-5.422048.648.6045.9
  -5.46%-5.30-5.322048.648.6045.9
  -5.46%-5.30-5.322048.648.6045.9
  -5.46%-5.30-5.322048.648.6045.9
  -5.46%-5.30-5.322048.648.6045.9
  -6.61%-3.20-3.211049.249.2045.9
  -6.33%-3.10-3.11104949045.9
  -6.33%-3.10-3.11104949045.9
  -6.33%-3.10-3.11104949045.9
  -6.33%-3.10-3.11104949045.9
  -3.10%-3-0.1-2.902148.848.848.745.9
  -6.13%-30-311048.948.9045.9
  -6.04%-2.90-2.911048.948.9045.9
  -6.04%-2.90-2.911048.948.9045.9
  -5.75%-2.80-2.811048.748.7045.9
  -5.75%-2.80-2.811048.748.7045.9
  -5.75%-2.80-2.811048.748.7045.9
  -5.75%-2.80-2.811048.748.7045.9
  -5.75%-2.80-2.811048.748.7045.9
  -5.75%-2.80-2.811048.748.7045.9
  -5.75%-2.80-2.811048.748.7045.9
  -5.75%-2.80-2.801048.748.748.945.9
  -5.65%-2.70-2.711048.748.7045.9
  -5.65%-2.70-2.711048.748.7045.9
  -5.65%-2.70-2.711048.748.7045.9
  -5.56%-2.70-2.711048.648.6045.9
  -5.56%-2.70-2.711048.648.6045.9
  -5.56%-2.70-2.711048.648.6045.9
國邑*用於PH-ILD臨床三期試驗藥品出貨 明年啟動收案Anue鉅亨-2025/12/08
國邑*授權夥伴將公布L606新藥臨床成果 年底前啟動PH-ILD全球三期Anue鉅亨-2025/08/14
國邑* 相關文章
國邑* 相關影音